Trial NCT04066491

View at ClinicalTrials.gov 
Org. Study IDs: MS200647_0055
Secondary IDs: 2019-001992-35

Last trial update was posted on 2023-11-14

MeSH Interventions

Gemcitabine

MeSH Conditions

Biliary Tract Neoplasms Cholangiocarcinoma Gallbladder Neoplasms

Other Conditions

Biliary Tract Cancer Gallbladder Cancer

Stopping Reasons

Based on a review of data conducted by the Independent Data Monitoring Committee (IDMC), Sponsor decided to discontinue this study as the study was unlikely to achieve the primary objective of overall survival.

Limitations And Caveats

Data collection and analysis of Pharmacokinetics and Immunogenicity were omitted and not conducted due to business reason.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID